Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
1.24
-0.06 (-4.62%)
At close: May 15, 2025, 3:59 PM
1.23
-0.40%
After-hours: May 15, 2025, 04:00 PM EDT
Sonnet BioTherapeutics Revenue Breakdown
| Period Ending | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|
| Better Burgers Fast Casual Revenue | 22.59M | 14.54M |
| Better Burgers Fast Casual Revenue Growth | +55.33% | n/a |
| Corporate and Other Revenue | 100K | 424.83K |
| Corporate and Other Revenue Growth | -76.46% | n/a |
| Hooters Full Service Revenue | 13.33M | 21.93M |
| Hooters Full Service Revenue Growth | -39.22% | n/a |
| Just Fresh Fast Casual Revenue | 5.68M | 5.5M |
| Just Fresh Fast Casual Revenue Growth | +3.38% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.34M | 1.96M | 1.97M | 1.8M | 1.7M | 653.46K | 1.79M | 1.54M | 1.88M | 1.9M | 2.32M | 2.28M | 1.9M | 2.08M | 2.39M | 2.35M | 2.2M | 2M | 2.78M | 2.48M | 1.18M | 1.06M | 1.57M | 1.71M | 102.23K | 98.06K | 1.09M | 1.12M | 1.19M | 1.31M | 952.96K | 1.08M | 1.38M | 1.43M | 1.35M | 1.37M | 1.76M | 1.68M | 2.08M | 1.9M |
| Selling, General, and Administrative Revenue Growth | +19.41% | -0.56% | +9.59% | +5.90% | +160.35% | -63.59% | +16.34% | -18.14% | -1.01% | -17.79% | +1.55% | +20.00% | -8.59% | -13.19% | +1.81% | +7.09% | +9.94% | -28.14% | +11.92% | +111.39% | +10.77% | -32.55% | -8.26% | +1576.94% | +4.25% | -91.02% | -2.60% | -6.01% | -9.05% | +37.70% | -12.12% | -21.17% | -3.62% | +5.64% | -1.73% | -21.93% | +5.03% | -19.46% | +9.65% | n/a |
| Research and Development Revenue | 1.88M | 1.89M | 1.2M | 1.73M | 2.15M | 624.07K | 1.84M | 2.41M | 3.82M | 3.75M | 5.12M | 5.65M | 6.41M | 4.27M | 5.04M | 3.89M | 3.84M | 3.87M | 4.71M | 2.46M | 1.3M | 1.41M | 1.58M | 391.91K | 166.43K | 57.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -0.06% | +57.32% | -30.58% | -19.55% | +244.00% | -66.13% | -23.53% | -36.87% | +1.89% | -26.89% | -9.29% | -11.81% | +50.15% | -15.29% | +29.54% | +1.22% | -0.66% | -17.94% | +91.83% | +88.54% | -7.50% | -11.04% | +303.91% | +135.49% | +187.02% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |